# Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects

> **NCT00920933** · PHASE1,PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** AIN457
- **OTHER:** Placebo
- **DRUG:** prednisolone

## Key facts

- **NCT ID:** NCT00920933
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-11
- **Final completion:** —
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920933, "Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00920933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*